Menopausal hot flushes revisited

Climacteric

Volumn 12, Issue 1, 2009, Pages 3-15

  Andrikoula, M ^a   Prelevic, G ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Estrogens; Hormone replacement treatment; Hot flushes; Menopause

Indexed keywords

ALPHA TOCOPHEROL; ANGELICA SINENSIS EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; CITALOPRAM; CLONIDINE; CONJUGATED ESTROGEN; COUMESTAN; DAIDZEIN; ESTRADIOL; FLUOXETINE; GABAPENTIN; GENISTEIN; GINSENG EXTRACT; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE ACETATE; PAROXETINE; PHYTOESTROGEN; PLACEBO; PRIMROSE OIL; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIBOLONE; UNCLASSIFIED DRUG; VENLAFAXINE;

ACUPUNCTURE; ANGELICA SINENSIS; BLOATING; BREAST CANCER; BREAST TENDERNESS; CANCER RISK; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; COLON CANCER; DIZZINESS; DROWSINESS; DRUG EFFICACY; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; EXERCISE; GENETIC POLYMORPHISM; GINSENG; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPOTHALAMUS; LIVER TOXICITY; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RED CLOVER; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT; UTERUS BLEEDING; VAGINA BLEEDING; XEROSTOMIA;

ACUPUNCTURE THERAPY; ADULT; ALCOHOL DRINKING; AMINES; CAFFEINE; CYCLOHEXANECARBOXYLIC ACIDS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; EXERCISE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; MENOPAUSE; MIDDLE AGED; PHYTOESTROGENS; SMOKING;

EID: 58149144410     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130802556296     Document Type: Review

References (176)

1. World Health Organisation Scientific Group. Menopause. WHO Technical Report Series, 866, 1996;Vol 7,issue 4:236-42
2. Freedman RR. Physiology of hot flashes. Am J Hum Biol 2001;13:453-64
3. Kronenberg F. Hot flashes: epidemiology and physiology. Ann NY Acad Sci 1990;592:52-86
4. Daly E, Gray A, Barlow D, McPherson K, Roche M, Vessey M. Measuring the impact of menopausal symptoms on quality of life. BMJ 1993;307:836-40
5. Oldenhave A, Netelenbos C. Pathogenesis of climacteric complaints: ready for the change? Lancet 1994;343:649-53
6. Staropoli CA, Flaws JA, Bush TL, Moulton AW. Predictors of menopausal hot flashes. J Women's Health 1998;7:1149-55
7. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes DF. Hot flushes. Lancet 2002;360:1851-61
8. Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bjorkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002;9:156-61
9. Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause and postmenopause life stages. Arch Womens Ment Health 2007;10:247-57
10. Thompson B, Hart SA, Durno D. Menopausal age and symptomatology in general practice. J Biosoc Sci 1973;5:71-82
11. McKinlay SM, Jeffreys M. The menopausal syndrome. Br J Prev Soc Med 1974;28:108-15
12. Williams RE, Kalilani L, Dibenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri- and postmenopasual women in the United States. Climacteric 2008;11:32-43
13. Jaszmann L, Lith ND, Zaat JCA. The perimenopausal symptoms: the statistical analysis of a survey. Med Gynaecol Sociol 1969;4:268-73
14. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007;10:197-214
15. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of Women's Health Across the Nation. Am J Publ Health 2006;96:1226-35
16. Lock M, Kaufert P, Gilbert P. Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 1988;10:317-32
17. Boulet MJ, Oddens BJ, Lehert P, Verner HM, Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 1994;19:205-9
18. Ho SC, Chan SG, Yip YB, Cheng A, Yi Q, Chan C. Menopausal symptoms and symptom clustering in Chinese women. Maturitas 1999;33:219-27
19. Chim H, Tan BH, Ang CC, Chew EM, Chong YS, Saw SM. The prevalence of menopausal symptoms in a community in Singapore. Maturitas 2002;41:275-82
20. Haines CJ, Xing SM, Park KH, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to therapy with three doses of conjugated oestrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-76
21. Hahn PM, Wong J, Reid RL. Menopausal-like hot flushes reported in women of reproductive age. Fertil Steril 1998;70:913-18
22. Guthrie JR, Dennerstein L, Hopper JL, Burger HG. Hot flushes, menstrual status and hormone levels in a population-based sample of midlife women. Obstet Gynecol 1996;88:437-42
23. Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463-73
24. Avis NE, Stellato R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345-56
25. Grisso JA, Freeman EW, Maurin E, Garcia-Espana B, Berlin JA. Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 1999;14:98-103
26. Miller SR, Gallicchio LM, Lewis LM, et al. Association between race and hot flashes in midlife women. Maturitas 2006;54:260-9
27. Schwingl PJ, Hulka BS, Harlow SD. Risk factors for menopausal hot flashes. Obstet Gynecol 1994;84:29-34
28. Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flushes are associated with increased ambulatory systolic blood pressure. Menopause 2007;14:308-15
29. Dennerstein L, Smith AM, Morse C, et al. Menopausal symptoms in Australian women. Med J Aust 1993;159:232-6
30. Avis NE, Crawford SL, McKinlay SM. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997;3:103-20
31. Freeman EW, Sammel MD, Grisso JA, Battistine M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for African American and Caucasian women. J Women's Health 2001;10:67-76
32. Whiteman MK, Staropoli C, Langenberg P, McCarter R, Kjerulff K, Flaws JA. Smoking, body mass and hot flushes in mid-life women. Obstet Gynecol 2003;101:264-72
33. Van Keep PA, Kellerhals JM. The impact of socio-cultural factors on symptom formation. Some results of a study on ageing women in Switzerland. Psychother Psychosom 1974;23:251-63
34. Flint MP. Sociology and anthropology of the menopause. In Van Keep PA, Serr DM, Greenblatt RB, eds. Female and Male Climacteric. Lancaster: MTP Press, 1979
35. Ginsburg J, Swinhoe J, O'Reilly B. Cardiovascular responses during the menopausal hot flush. Br J Obstet Gynaecol 1981;88:925-30
36. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Emotional antecedents of hot flushes during daily life. Psychosom Med 2005;67:137-46
37. Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-8
38. Avis NE, Crawford S, Stellato R, Longcope C. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001;4:243-9
39. Freeman EW, Sammel MD, Lin H, Gracia C, Kapoor S, Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005;12:258-66
40. Sturdee DW, Reece BL. Thermography of menopausal hot flushes. Maturitas 1979;1:201-5
41. Cignarelli M, Cicinelli E, Corso M, et al. Biophysical and endocrine-metabolic changes during menopausal hot flashes: increase in plasma free fatty acid and norepinephrine levels. Gynecol Obstet Invest 1989;27:34-7
42. De Bakker IP, Everaerd W. Measurement of menopausal hot flushes: validation and cross-validation. Maturitas 1996;25:87-98
43. Freedman RR, Woodward S, Mayes MM. Nonneural mediation of digital vasodilation during menopausal hot flushes. Gynecol Obstet Invest 1994;38:206-9
44. Wilkin JK. Why is flushing limited to a mostly facial cutaneous distribution? J Am Acad Dermatol 1988;19:309-13
45. Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989;26:573-9
46. Freedman RR, Norton D, Woodward S, Cornélissen G. Core body temperature and circadian rhythm of hot flashes in menopausal women. J Clin Endocrinol Metab 1995;80:2354-8
47. Carpenter JS, Andrykowski MA, Freedman RR, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999;6:209-15
48. Silverman RW, Bajorek JG, Lomax P, Tataryn IV. Monitoring the pathophysiological correlates of post-menopausal hot flushes. Maturitas 1981;3:39-46
49. Freedman RR, Wasson S. Miniature hygrometric hot flash recorder. Fertil Steril 2007;88:494-6
50. Kerslake DM, Cooper KE. Vasodilation in the hand in response to heating the skin elsewhere. Clin Sci 1950;9:31-47
51. Barcroft H, Bonnar WM, Edholm OG. Reflex vasodilation in human skeletal muscle in response to heating the body. J Physiol (Lond) 1947;106:271-8
52. Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. Br Med J 1989;298:1488-90
53. Freedman RR, Krell W. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 1999;181:66-70
54. Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000;31(Suppl 5):S157-61
55. Romanovsky AA. Thermoregulation: some concepts have changed. Functional architecture of the thermoregulatory system. Am J Physiol Regul Integr Comp Physiol 2007;292:R37-46
56. Freedman RR, Benton MD, Genik RJ 2nd, Graydon FX. Cortical activation during menopausal hot flashes. Fertil Steril 2006;85:674-8
57. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc 2002;77:1207-18
58. Berendsen HHG. The role of serotonin in hot flushes. Maturitas 2000;36:155-64
59. Brick JF. Hot flush epilepsy. South Med J 1988;81:88-91
60. Genazzani AR, Gambacciani M, Simoncini T, Schneider HPG. Hormone replacement therapy in climacteric and aging brain. Position Paper from the International Menopause Society Expert Workshop, Pisa, Italy, 15-18 March 2003. Climacteric 2003;6:188-203
61. Freedman RR, Woodward S, Sabharwal SC. α2-Adrenergic mechanism in menopausal hot flashes. Obstet Gynecol 1990;76:573-8
62. Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril 2000;74:20-3
63. Clayden JR, Bell JW, Pollard P. Menopausal flushing: double-blind trial of a non-hormonal medication. BMJ 1974;1:409-12
64. Nelson HD, Vesco K, Haney E. Clonidine, gabapentin and some SSRIs effective for hot flashes. J Fam Pract 2006;55:662.
65. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-45
66. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial. Lancet 2005;366:818-24
67. Loprinzi CL, Kugler JW, Barton DL, et al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007;25:308-12
68. Butt DA, Lock M, Lewis JE, Ross S, Moineddin R. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial. Menopause 2008;15:310-18
69. Slopien R, Meczekalski B, Warenik-Szymankiewicz A. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric 2003;6:53-7
70. Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes in women. J Support Oncol 2003;1:11-21
71. Deecher DC, Alfinito PD, Leventhal L, et al. Alleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlaflaxine succinate in ovariectomized rodent models. Endocrinology 2007;148:1376-83
72. Øverlie I, Moen MH, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 2002;41:69-77
73. Randolph JF Jr, Sowers M, Bondarenko I, et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 2005;90:6106-12
74. Randolph JF Jr, Sowers MF, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in oestradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-61
75. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women. Maturitas 1992;14:127-41
76. Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. A prospective population-based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8
77. Naessen T, Persson I, Ljunghall S, Bergstrom R. Women with climacteric symptoms: a target group for prevention of rapid bone loss and osteoporosis. Osteoporos Int 1992;2:225-31
78. Woods NF, Mitchell ES, Tao Y, Viernes HM, Stapleton PL, Farin FM. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2006;13:902-10
79. Schilling C, Gallicchio L, Miller SR, Langenberg P, Zacur H, Flaws JA. Genetic polymorphisms, hormone levels and hot flashes in midlife women. Maturitas 2007;57:120-31
80. Casper RF, Yen SSC. Neuroendocrinology of menopausal flushes: an hypothesis of flush mechanism. Clin Endocrinol (Oxf) 1985;22:293-312
81. Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med 2005;118(Suppl 12B):131-5
82. Mom CH, Buijs C, Willemse PH, Mourits MJ, de Vries EG. Hot flushes in breast cancer patients. Crit Rev Oncol Haematol 2006;57:63-77
83. Feldman JM, Postlethwaite RW, Glenn JF. Hot flushes and sweats in men with testicular insufficiency. Arch Intern Med 1976;136:606-8
84. Steinfeld AD, Reinhardt C. Male climacteric after orchidectomy in patient with prostatic cancer. Urology 1980;16:620-2
85. Linde R, Doelle GC, Alexander N, et al. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin- releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. N Engl J Med 1981;305:663-7
86. Casper RF, Yen SSC, Wilkes MM. Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979;205:823-5
87. Tataryn IV, Meldrum DR, Lu KH, Frumar AM, Judd HL. LH, FSH and skin temperature during the menopausal hot flush. J Clin Endocrinol Metab 1979;49:152-4
88. Casper RF, Yen SSC. Menopausal flushes: effect of pituitary gonadotrophin desensitization by a potent luteinizing hormone-releasing factor agonist. J Clin Endocrinol Metab 1981;53:1056-8
89. DeFazio J, Meldrum DR, Laufer L, et al. Induction of hot flushes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab 1983;56:445-8
90. Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flushes. Obstet Gynecol 1982;59:403-7
91. Ryan KJ, Berkowitz RS, Barbieri RV, Dunaif A, eds. Kistner's Gynaecology and Women's Health, 7th edn. St Louis: Mosby, 1999
92. Den Tonkelaar I, Seidell JC, van Noord PA. Obesity and fat distribution in relation to hot flashes in Dutch women from the DOM-project. Maturitas 1996;23:301-5
93. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005;23:117-25
94. Thurston RC, Sowers MR, Sutton-Tyrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-34
95. Anderson GS. Human morphology and temperature regulation. Int J Biometeorol 1999;43:99-109
96. Hormone-replacement therapy: safety update. UK Public Assessment Report, MHRA, September 2007, http://www.mhra. gov.uk/
97. MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004;(4):CD002978
98. Nelson HD. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 2004;291:1610-20
99. Good WR, John VA, Ramirez M, Higgins JE. Comparison of Alora estradiol matrix transdermal delivery system with oral conjugated equine estrogen therapy in relieving menopausal symptoms. Climacteric 1999;2:29-36
100. Kocjan T, Prelevic GM. Hormone replacement therapy update: who should we be prescribing this to now? Curr Opin Obstet Gynecol 2003;15:459-64
101. Stephenson J. FDA orders estrogen safety warnings: agency offers guidance for HRT use. JAMA 2003;289:537-8
102. Wyeth Pharmaceuticals website. Available at http://www.prempro.com. Accessed May 2008.
103. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-79
104. Gambacciani M, Ciaponi M, Cappagli B, et al. Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy. Maturitas 2003;45:175-83
105. Ettinger B. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage. Am J Med 2005;118(Suppl 2):74-8
106. Panay N, Ylikorkala O, Archer DF, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 2007;10:120-31
107. Grady D, Sawaya GF. Discontinuation of postmenopausal hormone therapy. Am J Med 2005;118(Suppl 2):163-5
108. Grady D, Wenger NK, Herrington D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000;132:689-96
109. Seibel MM. Treating hot flushes without hormone replacement therapy. J Fam Pract 2003;52:291-6
110. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
111. Bakken K, Eggen AE, Lund E. Side-effects of hormone replacement therapy and influence in pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstet Gynecol Scand 2004;83:850-6
112. Bjorn I, Backstrom T. Drug related negative side-effects are a common reason for poor compliance in hormone replacement therapy. Maturitas 1999;32:77-86
113. Newton KM, Buist DS, Keenan NL, Anderson LA, LaCroix AZ. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100:18-25
114. Hammar M, Christau S, Nathorst-Böös J, Rud T, Garre K. A double-blind, randomized trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105:904-11
115. Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23:55-62
116. Laan E, Van Lunsen RHW, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001;4:28-41
117. Lippuner K, Haenggi W, Birkhaeuser MH, Casez JP, Jaeger P. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone. J Bone Miner Res 1997;12:806-12
118. Cummings SR, Ettinger B, Delmas PD, et al. for the LIFT Trial Investigators. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359:697-708
119. Schiff I, Tulchinsky D, Cramer D, Ryan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptoms. JAMA 1980;244:1443-5
120. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA. Mergestrol acetate for the prevention of hot flushes. N Engl J Med 1994;331:347-52
121. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225-8
122. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001;4:144-50
123. Freedman RR. Current best treatment for hot flashes. Menopause Management 2006;15:20-5
124. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopause hot flashes: a randomized controlled trial. JAMA 2003;289:2827-34
125. Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-30
126. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlaflaxine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;356:2059-63
127. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlaflaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005;105:161-6
128. Albertazzi P. Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric 2007;10(Suppl 2):115-20
129. Gordon PR, Kerwin JP, Boesen KG, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 2006;13:546-8
130. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of post-menopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18-26
131. Loprinzi CL, Flynn PJ, Carpenter LA, et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlaflaxine. J Palliat Med 2005;8:924-30
132. Reddy SY, Warner H, Guttuso T Jr, et al. Gabapentin, estrogen and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006;108:41-8
133. Goldberg RM, Loprinzi CL, O'Fallon JR, et al. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 1994;12:155-8
134. Pandya KJ, Raubertas RF, Flynn PJ, et al. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 2000;132:788-93
135. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women. Lancet 1994;343:269-70
136. Tranquilli AL, Mazzanti L, Cugini AM, Cester N, Garzeti GG, Romanini C. Transdermal estradiol and medroxyprogesterone acetate in hormone replacement therapy are both antioxidant. Gynecol Endocrinol 1995;9:137-41
137. Meydany M. Vitamin E. Lancet 1995;345:170-5
138. Christy C. Vitamin E in menopause. Am J Obstet Gynecol 1945;50:84-7
139. McLaren H. Vitamin E in menopause. BMJ 1949;2:1378-81
140. Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flushes in breast cancer survivors. J Clin Oncol 1998;16:495-500
141. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol 1996;87:897-904
142. Thompson LU, Robb P, Serraino M. Mammalian lignan production from various foods. Nutr Canc 1991;16:43-52
143. Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 1998;83:297-303
144. Cassidy A, Bingham S, Carlson J, Setchell KDR. Biological effects of plant estrogens in premenopausal women. FASEB J 1993;A:866.
145. Cassidy A, Bingham S, Setchell KDR. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-40
146. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993;45:399-405
147. Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 2001;153:790-3
148. Williamson-Hughes PS, Flickinger BD, Messina MJ, Empie MW. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause 2006;13:831-9
149. Cheng G, Wilczek B, Warner M, Gustafsson JA, Landgren BM. Isoflavone treatment for acute menopausal symptoms. Menopause 2007;14:468-73
150. D'Anna R, Cannata ML, Atteritano M, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 2007;14:648-55
151. Sievert LL, Morrison L, Brown DE, Reza AM. Vasomotor symptoms among Japanese-American and European-American women living in Hilo, Hawaii. Menopause 2007;14:261-9
152. Booth NL, Piersen CE, Banuvar S, Geller SE, Shulman LP, Farnworth NR. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review. Menopause 2006;13:251-64
153. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: The Isoflavone Clover Extract (ICE) Study. A randomized controlled trial. JAMA 2003;290:207-14
154. Struck D, Tegtmeier M, Harnishfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Med 1997;63:289-90
155. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-45
156. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869-79
157. Page RL 2nd, Lawrence JD. Potentiation of warfarin by dong quai. Pharmacotherapy 1999;19:870-6
158. Chenoy R, Hussain S, Tayob Y, O'Brien PMS, Moss MY, Morse PF. Effect of oral gamalenic acid from evening primrose oil on menopausal flushing. BMJ 1994;308:501-3
159. Mahady GB, Low Dog T, Barrett ML, et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008;15:628-38
160. Joy D, Joy J, Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric. 2008 Feb;11(1):84-8
161. Chow EC, Teo M, Ring JA, Chen JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust. 2008 Apr 7;188(7):420-2
162. Hirata JD, Swiers LM, Zell B, Small R, Ettinger B. Does dong quai have estrogenic effects in postmenopausal women? A double-blind placebo-controlled trial. Fertil Steril 1997;68:981-6
163. Zaborowska E, Brynhildsen J, Damberg S, et al. Effects of acupuncture, applied relaxation, estrogens and placebo on hot flushes in postmenopausal women: an analysis of two prospective, parallel, randomized studies. Climacteric 2007;10:38-45
164. Huang MI, Nir Y, Chen B, Schnyer R, Manber R. A randomized controlled pilot study of acupuncture for postmenopausal hot flashes: effect on nocturnal hot flashes and sleep quality. Fertil Steril 2006;86:700-10
165. Vincent A, Barton DL, Mandrekar JN, et al. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause 2007;14:45-52
166. Carpenter JS, Neal JG. Other complementary and alternative medicine modalities: acupuncture, magnets, reflexology and homeopathy. Am J Med 2005;118(Suppl 12B):109-17
167. Nedrow A, Miller J, Walker M, Nygren P, Huffmann LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-65
168. The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11-33
169. Daley A, Stokes-Lampard H, Mutrie N, MacArthur C. Exercise for vasomotor symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4. Art No CD006108. DOI:10.1002/14651858. CD006108.pub2.
170. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. Hot flushes during the menopause transition: a longitudinal study in Australian-born women. Menopause 2005;12:460-7
171. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118(Suppl 12B):148-54
172. Grady D. Management of menopausal symptoms. N Engl J Med 2006;355:2338-47
173. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436-9
174. Nelson HD, Vesco KK, Haney E, et al. Non-hormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006;295:2057-71
175. Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4. Art No CD001395. DOI:10.1002/14651858. CD001395.pub3.
176. Krebbs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004;104:824-36